COMMUNIQUÉS West-GlobeNewswire

Axsome Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
28/08/2018
NEW YORK, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Agios to Present at the Citi 13th Annual Biotech Conference Wednesday, September 5, 2018
28/08/2018
CAMBRIDGE, Mass, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is [...]
EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences
28/08/2018
WATERTOWN, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Arcturus Therapeutics Appoints Andrew Sassine as Interim Chief Financial Officer
28/08/2018
SAN DIEGO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company, today announced that it has appointed Andrew Sassine as Interim Chief Financial Officer (CFO), [...]
Emerald Health Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
28/08/2018
VICTORIA, British Columbia, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that Chris Wagner, Chief Executive Officer, will present a corporate [...]
Revive Therapeutics Provides Corporate Update
28/08/2018
TORONTO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”) , a specialty cannabis company focused on the research, development and [...]
Radient Technologies Inc. Reports First Quarter 2019 Financial Results and Provides Corporate Update
28/08/2018
EDMONTON, Alberta, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) is pleased to announce financial results for the first fiscal quarter ended June 30, 2018 [...]
Dynavax Announces Publication of Two Papers in Leading Oncology Journal Highlighting Data From Clinical Studies of Its TLR9 Agonist, SD-101
28/08/2018
Cancer Discovery Features Reports of Early Clinical Trials of SD-101 in Lymphoma and Advanced Melanoma BERKELEY, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced [...]
Bhang Accelerates Growth with New Headquarters in Miami
28/08/2018
Recent Real Estate Deal Enables Bhang Corporation to Significantly Expand Operations MIAMI, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Bhang Corporation , the award-winning company famous for its Bhang-branded cannabis edibles, [...]
G1 Therapeutics to Present at H.C. Wainwright Investment Conference on September 5, 2018
28/08/2018
RESEARCH TRIANGLE PARK, N.C., Aug. 28, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Buck Phillips, Chief Financial Officer and Senior Vice [...]
Financial Calendar 2018/19
28/08/2018
Company Announcement No. 13/2018 Attachment No 13 2018_Financial Calendar 20182019
Transactions in relation to share buyback program
28/08/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Aino Health AB (publ): Aino Health signs agreement with Sjuksyrra AB
28/08/2018
28 August 2018 Because of increased demand for Aino Health's offering and to continue increasing scalability, Aino Health has signed an agreement with Sjuksyrra AB. Sjuksyrra AB is a staffing company in health care [...]
GENFIT: Major Milestone achieved with full recruitment of the Phase 2 trial evaluating elafibranor in PBC
28/08/2018
GENFIT: Major Milestone achieved with full recruitment of the Phase 2 trial evaluating elafibranor in PBC Final patient randomized in a Phase 2a clinical trial evaluating efficacy and safety of elafibranor in PBC ( [...]
GENFIT : étape importante franchie avec la fin du recrutement des patients de l'essai de Phase 2 évaluant elafibranor dans la PBC
28/08/2018
GENFIT : étape importante franchie avec la fin du recrutement des patients de l'essai de Phase 2 évaluant elafibranor dans la PBC Randomisation du dernier patient de l'essai de phase 2a évaluant l'efficacité et l' [...]
GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology
28/08/2018
VIENNA, Austria, Aug. 28, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the development and commercialization of cannabinoid prescription medicines, [...]
ObsEva SA to Participate in September Investor Conferences
28/08/2018
Geneva, Switzerland and Boston, MA – August 28, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
MDxHealth (R): SelectMDx Cost-effective in Four European Countries
28/08/2018
NEWS RELEASE REGULATED INFORMATION Potential healthcare cost savings in France, Germany, Italy and Spain of over €300 million IRVINE, CA, and HERSTAL, BELGIUM - 07.00 CEST, 28 August 2018 - MDxHealth SA (Euronext: MDXH. [...]
MDxHealth (R) :
28/08/2018

Pages